Information about the 2019 Novel Coronavirus
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
Trial ID or NCT#
This phase II trial is studying how well giving combination chemotherapy works in treating young patients with recurrent or resistant malignant germ cell tumors. Drugs used in chemotherapy, such as paclitaxel, ifosfamide, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin
Contact us to find out if this trial is right for you.
Peds Hem/Onc CRAs
About this Clinical Trial
Your Message Will Go ToPeds Hem/Onc CRAs
To:Peds Hem/Onc CRAs
Go Back To The Trial